Enovis (ENOV) Non Operating Investment Income (2018)

Enovis (ENOV) reported Non Operating Investment Income of -$28000.0 for Q4 2018, down 100.61% quarter-over-quarter from $4.6 million in Q2 2018.

Enovis (ENOV) Non Operating Investment Income (2018) Analysis & Trends

Enovis (ENOV) has 1 years of Non Operating Investment Income data on file, last reported at -$28000.0 in Q4 2018.

Non Operating Investment Income for Q4 2018 came in at -$28000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2019 was -$28000.0 (up 99.72% YoY), and the FY2018 annual result was -$10.1 million, changed N/A from the prior year.
Non Operating Investment Income slipped to -$28000.0 in Q4 2018 per ENOV's latest filing, from $4.6 million in the prior quarter.
Over five years, Non Operating Investment Income peaked at $4.6 million in Q2 2018 and troughed at -$14.7 million in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	-
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	-
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	-
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	-
10	Enovis	1.24 Bn	1.21 Bn	365.49 Mn	-

Download Data